Navidea Stock Gains After FDA Grants End Of Phase 2 Meeting To Discuss Rheumatoid Arthritis Program
EC Selects Antibody Therapies, Arthritis Drug As Preferred COVID-19 Meds: Reuters
Pfizer's Xeljanz Cuts Incidence Of Death, Respiratory Failure In COVID-19 Patients, Brazilian Study Shows
Lilly's Olumiant Found to Lower Pain In Late-Stage Rheumatoid Arthritis Trial
Rheumatoid Arthritis Recent News
AbbVie's Rinvoq Shows Encouraging Long Term Safety, Efficacy In Rheumatoid Arthritis, Psoriatic Arthritis Patients
Sorrento Reports Encouraging Data From Sofusa-Administered Enbrel In Rheumatoid Arthritis
Biogen, Bio-Thera Ink Licensing Agreement For Development Of Actemra-Based Biosimilar For Rheumatoid Arthritis
Provention Bio's CEO On Identifying Autoimmune Diseases 'Before It's Too Late'
Regeneron, Sanofi Announce FDA Has Accepted For Review BLA For Sarilumab